The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global MMR Vaccines Market Research Report 2024
Synopsis
The MMR vaccine (also known as the MPR vaccine after the Latin names of the diseases) is an immunization vaccine against measles, mumps, and rubella (German measles). It is a mixture of live attenuated viruses of the three diseases, administered via injection. It was first developed by Maurice Hilleman while at Merck.
The global MMR Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for MMR Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MMR Vaccines.
Report Scope
The MMR Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global MMR Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the MMR Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Medlmmune
Merck
Sanofi Pasteur
Serum Institute
Segment by Type
Monovalent
Combinational
Divalent
Trivalent
Segment by Application
Pediatrics
Adolescents
Adults
Elderly
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of MMR Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of MMR Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The MMR vaccine (also known as the MPR vaccine after the Latin names of the diseases) is an immunization vaccine against measles, mumps, and rubella (German measles). It is a mixture of live attenuated viruses of the three diseases, administered via injection. It was first developed by Maurice Hilleman while at Merck.
The global MMR Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for MMR Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MMR Vaccines.
Report Scope
The MMR Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global MMR Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the MMR Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Medlmmune
Merck
Sanofi Pasteur
Serum Institute
Segment by Type
Monovalent
Combinational
Divalent
Trivalent
Segment by Application
Pediatrics
Adolescents
Adults
Elderly
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of MMR Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of MMR Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 MMR Vaccines Market Overview
1.1 Product Overview and Scope of MMR Vaccines
1.2 MMR Vaccines Segment by Type
1.2.1 Global MMR Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Monovalent
1.2.3 Combinational
1.2.4 Divalent
1.2.5 Trivalent
1.3 MMR Vaccines Segment by Application
1.3.1 Global MMR Vaccines Market Value by Application: (2024-2030)
1.3.2 Pediatrics
1.3.3 Adolescents
1.3.4 Adults
1.3.5 Elderly
1.4 Global MMR Vaccines Market Size Estimates and Forecasts
1.4.1 Global MMR Vaccines Revenue 2019-2030
1.4.2 Global MMR Vaccines Sales 2019-2030
1.4.3 Global MMR Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 MMR Vaccines Market Competition by Manufacturers
2.1 Global MMR Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global MMR Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global MMR Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global MMR Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of MMR Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of MMR Vaccines, Product Type & Application
2.7 MMR Vaccines Market Competitive Situation and Trends
2.7.1 MMR Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest MMR Vaccines Players Market Share by Revenue
2.7.3 Global MMR Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 MMR Vaccines Retrospective Market Scenario by Region
3.1 Global MMR Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global MMR Vaccines Global MMR Vaccines Sales by Region: 2019-2030
3.2.1 Global MMR Vaccines Sales by Region: 2019-2024
3.2.2 Global MMR Vaccines Sales by Region: 2025-2030
3.3 Global MMR Vaccines Global MMR Vaccines Revenue by Region: 2019-2030
3.3.1 Global MMR Vaccines Revenue by Region: 2019-2024
3.3.2 Global MMR Vaccines Revenue by Region: 2025-2030
3.4 North America MMR Vaccines Market Facts & Figures by Country
3.4.1 North America MMR Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America MMR Vaccines Sales by Country (2019-2030)
3.4.3 North America MMR Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe MMR Vaccines Market Facts & Figures by Country
3.5.1 Europe MMR Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe MMR Vaccines Sales by Country (2019-2030)
3.5.3 Europe MMR Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific MMR Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific MMR Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific MMR Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific MMR Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America MMR Vaccines Market Facts & Figures by Country
3.7.1 Latin America MMR Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America MMR Vaccines Sales by Country (2019-2030)
3.7.3 Latin America MMR Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa MMR Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa MMR Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa MMR Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa MMR Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global MMR Vaccines Sales by Type (2019-2030)
4.1.1 Global MMR Vaccines Sales by Type (2019-2024)
4.1.2 Global MMR Vaccines Sales by Type (2025-2030)
4.1.3 Global MMR Vaccines Sales Market Share by Type (2019-2030)
4.2 Global MMR Vaccines Revenue by Type (2019-2030)
4.2.1 Global MMR Vaccines Revenue by Type (2019-2024)
4.2.2 Global MMR Vaccines Revenue by Type (2025-2030)
4.2.3 Global MMR Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global MMR Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global MMR Vaccines Sales by Application (2019-2030)
5.1.1 Global MMR Vaccines Sales by Application (2019-2024)
5.1.2 Global MMR Vaccines Sales by Application (2025-2030)
5.1.3 Global MMR Vaccines Sales Market Share by Application (2019-2030)
5.2 Global MMR Vaccines Revenue by Application (2019-2030)
5.2.1 Global MMR Vaccines Revenue by Application (2019-2024)
5.2.2 Global MMR Vaccines Revenue by Application (2025-2030)
5.2.3 Global MMR Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global MMR Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline MMR Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline MMR Vaccines Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Medlmmune
6.2.1 Medlmmune Corporation Information
6.2.2 Medlmmune Description and Business Overview
6.2.3 Medlmmune MMR Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medlmmune MMR Vaccines Product Portfolio
6.2.5 Medlmmune Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck MMR Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck MMR Vaccines Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Sanofi Pasteur
6.4.1 Sanofi Pasteur Corporation Information
6.4.2 Sanofi Pasteur Description and Business Overview
6.4.3 Sanofi Pasteur MMR Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Pasteur MMR Vaccines Product Portfolio
6.4.5 Sanofi Pasteur Recent Developments/Updates
6.5 Serum Institute
6.5.1 Serum Institute Corporation Information
6.5.2 Serum Institute Description and Business Overview
6.5.3 Serum Institute MMR Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Serum Institute MMR Vaccines Product Portfolio
6.5.5 Serum Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 MMR Vaccines Industry Chain Analysis
7.2 MMR Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 MMR Vaccines Production Mode & Process
7.4 MMR Vaccines Sales and Marketing
7.4.1 MMR Vaccines Sales Channels
7.4.2 MMR Vaccines Distributors
7.5 MMR Vaccines Customers
8 MMR Vaccines Market Dynamics
8.1 MMR Vaccines Industry Trends
8.2 MMR Vaccines Market Drivers
8.3 MMR Vaccines Market Challenges
8.4 MMR Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
